Los mejores oncohematólogos del tratamiento de Leucemia linfoblástica aguda — TOP-20 médicos
- El Prof. MD Zafer Gulbas está especializado en el tratamiento de la leucemia linfoblástica aguda (LLA) y el trasplante de médula ósea.
- Los métodos de tratamiento de la LLA incluyen quimioterapia, terapia dirigida, inmunoterapia y trasplante de médula ósea.
- Formación internacional en instituciones médicas de Israel, EE.UU. (Fred Hutchinson, M.D. Anderson) y Canadá (Princess Margaret Hospital).
- Director del Centro de Trasplante de Médula Ósea del Anadolu Medical Center desde 2005.
- Afiliaciones profesionales: Sociedad Turca de Hematología, Asociación Europea de Hematología y Sociedad Americana de Hematología.
| Cita con el médico | precio a consultar |
| Trasplante alogénico de médula ósea de un donante no emparentado | $85000 |
| Trasplante autólogo de médula ósea | $31000 |
| Trasplante de médula ósea | $35000 - $75000 |
acreditaciones:
- Especializado en el tratamiento de la leucemia linfoblástica aguda (LLA), incluida la quimioterapia, la terapia dirigida y la inmunoterapia.
- Tiene experiencia internacional en instituciones médicas de EE.UU., Reino Unido, Israel y Turquía.
- Certificado por la Sociedad Europea de Oncología Médica (ESMO), lo que garantiza un alto nivel en la atención oncológica.
- Miembro de la ESMO y de la Escuela Europea de Oncología (ESO), lo que refleja su compromiso con la formación continua.
- Habla inglés y turco con fluidez y tiene un nivel intermedio de ruso, lo que facilita la comunicación con los pacientes.
| Cita con el médico | precio a consultar |
| Trasplante alogénico de médula ósea de un donante no emparentado | $85000 |
| Trasplante autólogo de médula ósea | $31000 |
| Trasplante de médula ósea | $35000 - $75000 |
Areas of Interest
- Bone marrow transplantation
- Leukemia
- Lymphoma
- Multiple myeloma
- Thalassemia
- Bone marrow diseases
- Plasmapheresis
Education
2005 Graduated from Hacettepe University, Faculty of Medicine
2010 Hacettepe University, Faculty of Medicine Internal Medicine Specialist
2014 Ankara University, Faculty of Medicine Hematology Specialist
Experience
October 2010 - December 2010 Internal Medicine Specialist at Ankara Oncology Hospital
December 2010 - April 2011 Hematology Sub-branch Assistant at Ankara Oncology Hospital
September 2014 - May 2016 Hematology Specialist at Kütahya Dumlupınar University Evliya Çelebi Training and Research Hospital
May 2016 - March 2018 Ufuk University, Faculty of Medicine, Hematology Department Faculty Member
March 2018 - October 2018 Hitit University, Faculty of Medicine, Hematology Department Faculty Member
November 2018 - January 2019 Medical Park Bahçelievler Hematology and Bone Marrow Transplantation Unit physician
February 2019 - June 2022 Present Bayındır Söğütözü Hospital Hematology and Stem Cell Transplantation Unit, Assistant Physician in Charge
June 2022 - July 2022 Afyonkarahisar Health Sciences University, Head of Hematology Department
Qualification Certificates
Internal Medicine Board Qualification Certificate, 2009
Hematology Board Qualification Certificate, 2014
English Proficiency 2017/7 e-YDS Score: 71.25
Internal Medicine Specialization Thesis Addition of 9-Week Trastuzumab to Adjuvant Treatment in Both Positive Breast Cancer Patients Retrospective Analysis
Education Abroad
Between October and December 2007 (3 months) Intensive Care Education at University of Florida, United States
Between December 2013 and January 2014 (2 months) Flow Cytometry Education at Salamanca University, Spain
Courses, Awards, and Certificates
1 Year of Work Certificate in Bone Marrow Transplantation, 2017
Blood Banking and Transfusion Medicine Certificate 2017
“Physician of the Year” Award in Kütahya, 2014
Laboratory GMP, GLP, ISO /IEC 17025: 2012 Certificates, 2014
Good Clinical Practices Certificate, 2013
Şeref Zileli Successful Assistant of the Year Award, 2009
RIA Certificate, 2005
Research and Publications
Patent
1. Half antibody with the fc portion removed (fab) for medical use. Inventor: Mehmet Özen. No:2016/0910. Patent under review.
Scientific Studies
A. Publications in International Journals under SCI Expanded
Turkish book section
1. Ozen M, Konuk N. Immune thrombocytopenic purpura. Turkoz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.8-12.
2. Özen M, Ural AU. Hematological diseases and mesenchymal stem cell applications. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.91-4.
3. Ozen M. Hematopoiesis and Hematopoietic Growth Factors. MediHealth & Hippocrates INTERNAL DISEASES with Current Guidelines 2022. p1607-10
Mostrar másRevisado por el CEO de Bookimed